Products for Research Use Only
RegisterLogin

AZD5069

CAT: 0957-S6645-25mgSize: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S6645-25mgSize:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
878385-84-3
Target
CXCR
Applications
GPCR & G Protein
Smiles
CC (C (CO) O) OC1=NC (=NC (=C1) NS (=O) (=O) N2CCC2) SCC3=C (C (=CC=C3) F) F
Molecular Formula
C18H22F2N4O5S2
Additionnal Information
AZD5069 is a novel antagonist of CXCR2, which is shown to inhibit binding of CXCL8 to CXCR2 with a pIC50 value of 8.8 and inhibit CXCL8 binding to CXCR1 with pIC50 values of 6.5.
Storage Conditions
3 years -20°C powder

Chemical Information

Azd-5069

CXC Chemokine Receptor 2 Antagonist AZD5069 is an orally bioavailable, selective and reversible antagonist of CXC chemokine receptor 2 (CXCR2), with potential anti-inflammatory and antineoplastic activities. Upon administration, CXC chemokine receptor 2 antagonist AZD5069 directly binds to CXCR2 and inhibits its activation. This inhibits CXCR2-mediated signaling and may inhibit tumor cell proliferation in CXCR2-overexpressing tumor cells. In addition, AZD5069 reduces both neutrophil recruitment and migration from the systemic circulation into sites of inflammation, including the lung mucosa; it may also prevent neutrophil migration from the bone marrow. This results in the reduction of inflammation, mucus production, and neutrophil proteinase-mediated tissue destruction in the lung. CXCR2, a G protein-coupled receptor protein also known as IL-8 receptor B (IL-8RB), is upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation and progression; it is known to be elevated in several inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and fibrotic pulmonary disorders.

CAS Number878385-84-3
PubChem CID56645576
IUPAC NameN-[2-[(2,3-difluorophenyl)methylsulfanyl]-6-[(2R,3S)-3,4-dihydroxybutan-2-yl]oxypyrimidin-4-yl]azetidine-1-sulfonamide
Molecular FormulaC18H22F2N4O5S2
Molecular Weight476.5
XLogP1.5
Topological Polar Surface Area159
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count12
Rotatable Bond Count10
Heavy Atom Count31
Formal Charge0
Complexity670
SMILES
C[C@H]([C@H](CO)O)OC1=NC(=NC(=C1)NS(=O)(=O)N2CCC2)SCC3=C(C(=CC=C3)F)F
InChI
InChI=1S/C18H22F2N4O5S2/c1-11(14(26)9-25)29-16-8-15(23-31(27,28)24-6-3-7-24)21-18(22-16)30-10-12-4-2-5-13(19)17(12)20/h2,4-5,8,11,14,25-26H,3,6-7,9-10H2,1H3,(H,21,22,23)/t11-,14+/m1/s1
InChIKey
QZECRCLSIGFCIO-RISCZKNCSA-N
Chemical Structure
2D Structure
2D structure of Azd-5069
CAS: 878385-84-3
CID: 56645576
Formula: C18H22F2N4O5S2
MW: 476.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight476.5
XLogP31.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count12
Rotatable Bond Count10
Exact Mass476.09996849
Monoisotopic Mass476.09996849
Topological Polar Surface Area159 Ų
Heavy Atom Count31
Formal Charge0
Complexity670
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
S8019-1gCapivasertib (AZD5363)
E1827-1mgECC5004 (AZD5004)
E1827-01ECC5004 (AZD5004)
E1827-5mgECC5004 (AZD5004)
S8019-5mgCapivasertib (AZD5363)
S8019-10mM/1mLCapivasertib (AZD5363)
S8019-100mgCapivasertib (AZD5363)
E1827-25mgECC5004 (AZD5004)
S8019-25mgCapivasertib (AZD5363)
S8019-01Capivasertib (AZD5363)

Alternative Products

CatalogName
C12086-10mM/1mLAZD5069

Popular Products